Written by Bill Rusnak. Endo Pharma (NASDAQ:ENDP) quietly closed 0.11 points lower today at 35.97. The company's drug Fortesta, a testosterone replacement for men, has its PDUFA action goal date coming up on 12/30/10.
Sorry this page is available to subscribers only. If you're not a subscriber why not join today?
You can also sign up for our 100% FREE Newsletter to stay current on public webinars, special offers, and news alerts: